Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study
M Davidov, C Perry, Y Herishanu, N Sarid, E Rom… - Annals of …, 2018 - Springer
High-dose therapy followed by autologous hematopoietic cell transplantation (HCT)
prolongs overall survival in patients under 65 years old with relapsed aggressive lymphoma …
prolongs overall survival in patients under 65 years old with relapsed aggressive lymphoma …